Loading APLS...
Apellis Pharmaceuticals Inc.APLSAs of 15 May 2026
Public engagement data
Reactive Search·
Cumulative Search·
Investigative Research·
−300−1500+150+300
8
PositiveNegative
Equilibrium
CheapExpensive
FearGreed
WeakStrong
Emotion

Is Apellis Pharmaceuticals Inc. oversold, or is the crowd euphoric?

A read on the market's emotion around Apellis Pharmaceuticals Inc. (APLS): where sentiment sits between capitulation and euphoria, measured against the stock's own history so heavily covered and quieter names read on the same scale. Information, not advice.

Apellis Pharmaceuticals Inc.APLSLast 5 years
VEFA
APLS priceasymmetryquant.com